|
Symbol
|
QQHRCH | LBBRDU | EFCCBL | LJZCLK |
|---|---|---|---|---|
| Name | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | LUKB Autocallable Multi Barrier Reverse Convertible |
|
Underlying
|
AstraZeneca / GlaxoSmithKline / Sanofi-Aventis | AstraZeneca Plc. / BioNTech SE / Novartis AG | AstraZeneca Plc. / Eli Lilly & Co. / Merck & Co. Inc. / Sandoz Group AG | AstraZeneca Plc. / Novo Nordisk AS (B) / Sanofi S.A. |
|
Issuer
|
|
|
|
|
|
Date of maturity
|
30.12.2026 | 08.04.2027 | 01.07.2027 | 20.08.2027 |
| Bid | 100.52 | 96.70 | 97.49 | - |
| Ask | 101.33 | 97.70 | 98.29 | - |